Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥181.00 JPY
Change Today -7.00 / -3.72%
Volume 282.9K
2369 On Other Exchanges
As of 2:00 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

medibic group (2369) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/22/15 - ¥308.00
52 Week Low
08/25/15 - ¥165.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDIBIC GROUP (2369)

Related News

No related news articles were found.

medibic group (2369) Related Businessweek News

No Related Businessweek News Found

medibic group (2369) Details

MediBIC Group provides healthcare and drug development services. It provides genetic testing services with diagnostic tools to doctors; GLP-compliant gene profiling services to pharmaceutical companies; and sample banking and management services, as well as focuses on providing health care services to pets. The company is also involved in developing a cell culture system; selling consumables; promoting licensing activities for the pancreatic cancer drug Glufosfamide; the research and development of pharmaceuticals and diagnostic agents, etc.; and providing data analysis for preventive health care, as well as clinical trial services to cell therapy. MediBIC Group was founded in 2000 and is headquartered in Tokyo, Japan.

29 Employees
Last Reported Date: 03/30/15
Founded in 2000

medibic group (2369) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medibic group (2369) Key Developments

MediBIC Group Co. Ltd. Announces the Consolidated Earnings Results for the Six Months Ended June 30, 2015; Provides Consolidated Earnings Guidance for the Year Ending December 2015

MediBIC Group Co. Ltd. announced the consolidated earnings results for the six months ended June 30, 2015. For the six months, the company reported net sales of JPY 47 million against JPY 81 million a year ago. Operating loss was JPY 236 million against JPY 227 million a year ago. Ordinary loss was JPY 261 million against JPY 232 million a year ago. Net loss was JPY 267 million against JPY 258 million a year ago. Net loss per share was JPY 9.13 against JPY 9.00 a year ago. The company also provided consolidated earnings guidance for the year ending December 2015. For the period, the company expects to report net sales of JPY 313 million, operating loss of JPY 220,000 million, ordinary loss of JPY 250 million, net loss of JPY 256 million and net loss per share of JPY 8.72.

MediBIC Group to Report Q2, 2015 Results on Aug 12, 2015

MediBIC Group announced that they will report Q2, 2015 results on Aug 12, 2015

Medibic Group, Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Six Months Ending June 2015 and Year Ending December 31, 2015

MediBIC Group, Co., Ltd. reported consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported consolidated net sales of JPY 35 million against JPY 49 million a year ago. Operating loss JPY 113 million against JPY 109 million a year ago. Ordinary loss was JPY 139 million against JPY 117 million a year ago. Net loss was JPY 145 million or JPY 4.98 per share against JPY 138 million or JPY 4.90 per share a year ago. For the six months ending June 2015, the company expects consolidated net sales of JPY 117 million, operating loss JPY 202 million, ordinary loss of JPY 200 million and net loss of JPY 201 million or JPY 117 per share. For the year ending December 31, 2015, the company expects consolidated net sales of JPY 704 million operating income of JPY 6 million ordinary income of JPY 10 million and net income of JPY 10 million or JPY 0.35 per share.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2369:JP ¥181.00 JPY -7.00

2369 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2369.
View Industry Companies

Industry Analysis


Industry Average

Valuation 2369 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.9x
Price/Book 7.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 17.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIBIC GROUP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at